Cargando…
Azithromycin: The First Broad-spectrum Therapeutic
The Strategic Plan for Biodefense Research by the U.S. Department of Health and Human Services demarcates the need for drugs which target multiple types of pathogens to prepare for infectious threats. Azithromycin is one such broad-spectrum therapeutic that is both included in the University of Oxfo...
Autores principales: | Firth, Anton, Prathapan, Praveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434625/ https://www.ncbi.nlm.nih.gov/pubmed/32871342 http://dx.doi.org/10.1016/j.ejmech.2020.112739 |
Ejemplares similares
-
WITHDRAWN: Azithromycin: The First Broad-spectrum
Therapeutic
por: Kruger, Donna, et al.
Publicado: (2020) -
Broad-spectrum therapeutics: A new antimicrobial class
por: Firth, Anton, et al.
Publicado: (2020) -
Broad-Spectrum Antiviral Therapeutics
por: Rider, Todd H., et al.
Publicado: (2011) -
mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases
por: Walters, Hannah E., et al.
Publicado: (2018) -
dsRNA as broad-spectrum antiviral therapeutics
por: Xu, Congfei
Publicado: (2022)